[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific RNA Interference (RNAi) Drug Delivery Market Report 2017

July 2017 | 116 pages | ID: ADEF9D65CC6EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific RNA Interference (RNAi) Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of RNA Interference (RNAi) Drug Delivery for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific RNA Interference (RNAi) Drug Delivery market competition by top manufacturers/players, with RNA Interference (RNAi) Drug Delivery sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Metabolic disorders
  • Alnylam Pharmaceuticals Inc
  • Merck & Co. Inc
  • Access Pharmaceuticals Inc
  • Dicerna Pharmaceuticals Inc
  • Calondo Pharmaceuticals Inc
  • Marina Biotech Inc
  • RXi Pharmaceuticals Corp
  • Quark Pharmaceuticals Inc
  • Silence Therapeutics plc
  • Tacere Therapeutics Inc
  • PhaseRx Inc
  • Sirnaomics Inc
  • Traversa Therapeutics Inc
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Nanoparticle Drug Delivery Technology
  • Pulmonary Drug Delivery Technology
  • Nucleic Acid Drug Delivery Technology
  • Aptamer Drug Delivery Technology
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of RNA Interference (RNAi) Drug Delivery for each application, includin
  • Infectious Diseases
  • Cardiology
  • Oncology
  • Neurology
  • Ophthalmology
  • Metabolic Disorders
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific RNA Interference (RNAi) Drug Delivery Market Report 2017

1 RNA INTERFERENCE (RNAI) DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of RNA Interference (RNAi) Drug Delivery
1.2 Classification of RNA Interference (RNAi) Drug Delivery by Product Category
  1.2.1 Asia-Pacific RNA Interference (RNAi) Drug Delivery Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific RNA Interference (RNAi) Drug Delivery Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Nanoparticle Drug Delivery Technology
  1.2.4 Pulmonary Drug Delivery Technology
  1.2.5 Nucleic Acid Drug Delivery Technology
  1.2.6 Aptamer Drug Delivery Technology
1.3 Asia-Pacific RNA Interference (RNAi) Drug Delivery Market by Application/End Users
  1.3.1 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Infectious Diseases
  1.3.3 Cardiology
  1.3.4 Oncology
  1.3.5 Neurology
  1.3.6 Ophthalmology
  1.3.7 Metabolic Disorders
1.4 Asia-Pacific RNA Interference (RNAi) Drug Delivery Market by Region
  1.4.1 Asia-Pacific RNA Interference (RNAi) Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of RNA Interference (RNAi) Drug Delivery (2012-2022)
  1.5.1 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC RNA INTERFERENCE (RNAI) DRUG DELIVERY COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific RNA Interference (RNAi) Drug Delivery Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific RNA Interference (RNAi) Drug Delivery (Volume and Value) by Type
  2.2.1 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific RNA Interference (RNAi) Drug Delivery (Volume) by Application
2.4 Asia-Pacific RNA Interference (RNAi) Drug Delivery (Volume and Value) by Region
  2.4.1 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue and Market Share by Region (2012-2017)

3 CHINA RNA INTERFERENCE (RNAI) DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

3.1 China RNA Interference (RNAi) Drug Delivery Sales and Value (2012-2017)
  3.1.1 China RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2012-2017)
  3.1.2 China RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2012-2017)
  3.1.3 China RNA Interference (RNAi) Drug Delivery Sales Price Trend (2012-2017)
3.2 China RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Type
3.3 China RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Application

4 JAPAN RNA INTERFERENCE (RNAI) DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

4.1 Japan RNA Interference (RNAi) Drug Delivery Sales and Value (2012-2017)
  4.1.1 Japan RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2012-2017)
  4.1.3 Japan RNA Interference (RNAi) Drug Delivery Sales Price Trend (2012-2017)
4.2 Japan RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Type
4.3 Japan RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Application

5 SOUTH KOREA RNA INTERFERENCE (RNAI) DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea RNA Interference (RNAi) Drug Delivery Sales and Value (2012-2017)
  5.1.1 South Korea RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea RNA Interference (RNAi) Drug Delivery Sales Price Trend (2012-2017)
5.2 South Korea RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Type
5.3 South Korea RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Application

6 TAIWAN RNA INTERFERENCE (RNAI) DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan RNA Interference (RNAi) Drug Delivery Sales and Value (2012-2017)
  6.1.1 Taiwan RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan RNA Interference (RNAi) Drug Delivery Sales Price Trend (2012-2017)
6.2 Taiwan RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Type
6.3 Taiwan RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Application

7 INDIA RNA INTERFERENCE (RNAI) DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

7.1 India RNA Interference (RNAi) Drug Delivery Sales and Value (2012-2017)
  7.1.1 India RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2012-2017)
  7.1.2 India RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2012-2017)
  7.1.3 India RNA Interference (RNAi) Drug Delivery Sales Price Trend (2012-2017)
7.2 India RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Type
7.3 India RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Application

8 SOUTHEAST ASIA RNA INTERFERENCE (RNAI) DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia RNA Interference (RNAi) Drug Delivery Sales and Value (2012-2017)
  8.1.1 Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Price Trend (2012-2017)
8.2 Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Type
8.3 Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Application

9 AUSTRALIA RNA INTERFERENCE (RNAI) DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

9.1 Australia RNA Interference (RNAi) Drug Delivery Sales and Value (2012-2017)
  9.1.1 Australia RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2012-2017)
  9.1.3 Australia RNA Interference (RNAi) Drug Delivery Sales Price Trend (2012-2017)
9.2 Australia RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Type
9.3 Australia RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share by Application

10 ASIA-PACIFIC RNA INTERFERENCE (RNAI) DRUG DELIVERY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Metabolic disorders
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Alnylam Pharmaceuticals Inc
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Merck & Co. Inc
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Access Pharmaceuticals Inc
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Dicerna Pharmaceuticals Inc
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Calondo Pharmaceuticals Inc
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Marina Biotech Inc
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 RXi Pharmaceuticals Corp
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Quark Pharmaceuticals Inc
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Silence Therapeutics plc
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Tacere Therapeutics Inc
10.12 PhaseRx Inc
10.13 Sirnaomics Inc
10.14 Traversa Therapeutics Inc

11 RNA INTERFERENCE (RNAI) DRUG DELIVERY MANUFACTURING COST ANALYSIS

11.1 RNA Interference (RNAi) Drug Delivery Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of RNA Interference (RNAi) Drug Delivery

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 RNA Interference (RNAi) Drug Delivery Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of RNA Interference (RNAi) Drug Delivery Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET FORECAST (2017-2022)

15.1 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific RNA Interference (RNAi) Drug Delivery Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China RNA Interference (RNAi) Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan RNA Interference (RNAi) Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea RNA Interference (RNAi) Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan RNA Interference (RNAi) Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India RNA Interference (RNAi) Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia RNA Interference (RNAi) Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia RNA Interference (RNAi) Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific RNA Interference (RNAi) Drug Delivery Price Forecast by Type (2017-2022)
15.4 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of RNA Interference (RNAi) Drug Delivery
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type (Product Category) in 2016
Figure Nanoparticle Drug Delivery Technology Product Picture
Figure Pulmonary Drug Delivery Technology Product Picture
Figure Nucleic Acid Drug Delivery Technology Product Picture
Figure Aptamer Drug Delivery Technology Product Picture
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of RNA Interference (RNAi) Drug Delivery by Application in 2016
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Neurology Examples
Table Key Downstream Customer in Neurology
Figure Ophthalmology Examples
Table Key Downstream Customer in Ophthalmology
Figure Metabolic Disorders Examples
Table Key Downstream Customer in Metabolic Disorders
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Market Size (Million USD) by Region (2012-2022)
Figure China RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure India RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Share by Players/Suppliers
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue Share by Players
Figure 2017 Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue Share by Players
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales and Market Share by Type (2012-2017)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Share by Type (2012-2017)
Figure Sales Market Share of RNA Interference (RNAi) Drug Delivery by Type (2012-2017)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue Share by Type (2012-2017)
Figure Revenue Market Share of RNA Interference (RNAi) Drug Delivery by Type (2012-2017)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Share by Region (2012-2017)
Figure Sales Market Share of RNA Interference (RNAi) Drug Delivery by Region (2012-2017)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Market Share by Region in 2016
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of RNA Interference (RNAi) Drug Delivery by Region (2012-2017)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region in 2016
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2012-2017)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2012-2017)
Figure China RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure China RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure China RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit) Trend (2012-2017)
Table China RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Type (2012-2017)
Table China RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure China RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type in 2016
Table China RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Applications (2012-2017)
Table China RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure China RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application in 2016
Figure Japan RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Japan RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit) Trend (2012-2017)
Table Japan RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Type (2012-2017)
Table Japan RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure Japan RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type in 2016
Table Japan RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Applications (2012-2017)
Table Japan RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure Japan RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application in 2016
Figure South Korea RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Type (2012-2017)
Table South Korea RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure South Korea RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type in 2016
Table South Korea RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Applications (2012-2017)
Table South Korea RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure South Korea RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application in 2016
Figure Taiwan RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Type (2012-2017)
Table Taiwan RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure Taiwan RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type in 2016
Table Taiwan RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure Taiwan RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application in 2016
Figure India RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure India RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure India RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit) Trend (2012-2017)
Table India RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Type (2012-2017)
Table India RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure India RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type in 2016
Table India RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Application (2012-2017)
Table India RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure India RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application in 2016
Figure Southeast Asia RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type in 2016
Table Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application in 2016
Figure Australia RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Australia RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit) Trend (2012-2017)
Table Australia RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Type (2012-2017)
Table Australia RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure Australia RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type in 2016
Table Australia RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) by Applications (2012-2017)
Table Australia RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure Australia RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Application in 2016
Table Metabolic disorders RNA Interference (RNAi) Drug Delivery Basic Information List
Table Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Metabolic disorders RNA Interference (RNAi) Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Basic Information List
Table Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Basic Information List
Table Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Basic Information List
Table Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Basic Information List
Table Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Basic Information List
Table Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Basic Information List
Table Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Basic Information List
Table RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Basic Information List
Table Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Basic Information List
Table Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Basic Information List
Table PhaseRx Inc RNA Interference (RNAi) Drug Delivery Basic Information List
Table Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Basic Information List
Table Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA Interference (RNAi) Drug Delivery
Figure Manufacturing Process Analysis of RNA Interference (RNAi) Drug Delivery
Figure RNA Interference (RNAi) Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of RNA Interference (RNAi) Drug Delivery Major Manufacturers in 2016
Table Major Buyers of RNA Interference (RNAi) Drug Delivery
Table Distributors/Traders List
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue Market Share Forecast by Region in 2022
Figure China RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific RNA Interference (RNAi) Drug Delivery Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories